Literature DB >> 33571106

Quantifying asymptomatic infection and transmission of COVID-19 in New York City using observed cases, serology, and testing capacity.

Rahul Subramanian1, Qixin He1, Mercedes Pascual2,3.   

Abstract

The contributions of asymptomatic infections to herd immunity and community transmission are key to the resurgence and control of COVID-19, but are difficult to estimate using current models that ignore changes in testing capacity. Using a model that incorporates daily testing information fit to the case and serology data from New York City, we show that the proportion of symptomatic cases is low, ranging from 13 to 18%, and that the reproductive number may be larger than often assumed. Asymptomatic infections contribute substantially to herd immunity, and to community transmission together with presymptomatic ones. If asymptomatic infections transmit at similar rates as symptomatic ones, the overall reproductive number across all classes is larger than often assumed, with estimates ranging from 3.2 to 4.4. If they transmit poorly, then symptomatic cases have a larger reproductive number ranging from 3.9 to 8.1. Even in this regime, presymptomatic and asymptomatic cases together comprise at least 50% of the force of infection at the outbreak peak. We find no regimes in which all infection subpopulations have reproductive numbers lower than three. These findings elucidate the uncertainty that current case and serology data cannot resolve, despite consideration of different model structures. They also emphasize how temporal data on testing can reduce and better define this uncertainty, as we move forward through longer surveillance and second epidemic waves. Complementary information is required to determine the transmissibility of asymptomatic cases, which we discuss. Regardless, current assumptions about the basic reproductive number of severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) should be reconsidered.
Copyright © 2021 the Author(s). Published by PNAS.

Entities:  

Keywords:  COVID-19; asymptomatic transmission; epidemiological model; epidemiological parameter estimates; testing submodel

Year:  2021        PMID: 33571106     DOI: 10.1073/pnas.2019716118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  62 in total

1.  Durability analysis of the highly effective BNT162b2 vaccine against COVID-19.

Authors:  Arjun Puranik; Patrick J Lenehan; John C O'Horo; Colin Pawlowski; Michiel J M Niesen; Abinash Virk; Melanie D Swift; Walter Kremers; A J Venkatakrishnan; Joel E Gordon; Holly L Geyer; Leigh Lewis Speicher; Venky Soundararajan; Andrew D Badley
Journal:  PNAS Nexus       Date:  2022-06-08

2.  COVID-19 in Missouri 2020-2021: A Perspective on Origins, Spread & Controversies Part II.

Authors:  David S McKinsey; Joel P McKinsey; Neil B Hampson; Maithe Enriquez
Journal:  Mo Med       Date:  2022 May-Jun

3.  Asymptomatic Cases, the Hidden Challenge in Predicting COVID-19 Caseload Increases.

Authors:  Brett Snider; Bhumi Patel; Edward McBean
Journal:  Infect Dis Rep       Date:  2021-04-09

4.  An international comparison of anti-SARS-COV-2 assays used for seroprevalence surveys from blood component providers.

Authors:  Antoine Lewin; Steven J Drews; Ryanne Lieshout-Krikke; Christian Erikstrup; Sahar Saeed; Helen Fady; Samra Uzicanin; Brian Custer; Sheila F O'Brien
Journal:  Vox Sang       Date:  2021-04-29       Impact factor: 2.996

5.  Higher Viral Load Drives Infrequent Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Between Asymptomatic Residence Hall Roommates.

Authors:  Kristen K Bjorkman; Tassa K Saldi; Erika Lasda; Leisha Conners Bauer; Jennifer Kovarik; Patrick K Gonzales; Morgan R Fink; Kimngan L Tat; Cole R Hager; Jack C Davis; Christopher D Ozeroff; Gloria R Brisson; Daniel B Larremore; Leslie A Leinwand; Matthew B McQueen; Roy Parker
Journal:  J Infect Dis       Date:  2021-10-28       Impact factor: 5.226

6.  Transmission Dynamics, Heterogeneity and Controllability of SARS-CoV-2: A Rural-Urban Comparison.

Authors:  Yuying Li; Taojun Hu; Xin Gai; Yunjun Zhang; Xiaohua Zhou
Journal:  Int J Environ Res Public Health       Date:  2021-05-14       Impact factor: 3.390

7. 

Authors:  Michael Liu; Rahul K Arora; Mel Krajden
Journal:  CMAJ       Date:  2021-06-07       Impact factor: 8.262

8.  Optimal allocation of limited vaccine to minimize the effective reproduction number.

Authors:  Isabelle J Rao; Margaret L Brandeau
Journal:  Math Biosci       Date:  2021-06-30       Impact factor: 2.144

9.  Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020.

Authors:  Ralf Wagner; David Peterhoff; Stephanie Beileke; Felix Günther; Melanie Berr; Sebastian Einhauser; Anja Schütz; Hans Helmut Niller; Philipp Steininger; Antje Knöll; Matthias Tenbusch; Clara Maier; Klaus Korn; Klaus J Stark; André Gessner; Ralph Burkhardt; Michael Kabesch; Holger Schedl; Helmut Küchenhoff; Annette B Pfahlberg; Iris M Heid; Olaf Gefeller; Klaus Überla
Journal:  Viruses       Date:  2021-06-10       Impact factor: 5.048

10. 

Authors:  Kevin L Schwartz; Allison J McGeer; Isaac I Bogoch
Journal:  CMAJ       Date:  2021-06-07       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.